How Foundation Medicine is creating shareholder value.
Read more
Awesome!
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond. Using mass spectrometry, an analytical instrument for sensitive detection and accurate identification of molecules, the team will quantitate the amount of anti-cancer drugs present in individual cancer cells, including those in bladder cancer cells isolated from patients undergoing chemotherapy. The method will provide a means to establish ideal dosing regimens that delivers effective chemotherapeutic concentrations to patients with minimal toxicities.
Anthony Burgett and Zhibo Yang, assistant professors in the Department of Chemistry and Biochemistry in the OU College of Arts and Sciences, and affiliates of the Stephenson Cancer Center, in collaboration with Jonathan E. Heinlen, M.D., assistant professor in the Department of Urology at the OU Health Sciences Center and a Stephenson Cancer Center researcher, will fully develop the novel first-in-class mass spectrometric technology—the Single Probe—capable of performing single-cell mass spectrometry of compounds inside of living single cancer cells as a bioanalytical method to improve efficacy and toxicities of chemotherapy in patients.
“One clear lesson from scientific progress is that new technologies often lead to major advances. This new single cancer cell mass spectrometry analysis could propel us forward to a new frontier in biological analysis, and we are excited to see where this technology, with its possible scientific and biomedical applications, could lead,” said Burgett.
Read more
I told many people that this was coming a few years ago; so glad. Wait until you see smart meds that people can never become addicted or overdose on because the smart med reads your system and knows when enough is enough.
The security solutions company uses botanical-DNA based tools to tag, track, and trace products for an array of industries. Now with the hire of a personal care supply chain management expert, the company is set to expand its engagement with the industry.
This week the Stony Brook, New York–based company announced that Barbara Brockway has accepted the role of Director of Personal Care.
Besides her experience in supply chain management, Brockway is also well versed in cosmetics formulation, food science, and branding, according to the company bio included in the statement announcing her appointment.
Nice.
Renowned physicist, author and broadcaster, Professor Jim Al-Khalili OBE, has been awarded the inaugural Stephen Hawking Medal for Science Communication.
Professor Jim Al-Khalili is the first person to be honoured for his contribution to science with this, first medal of its kind, at STARMUS International Science and Arts Festival in Tenerife on 29 June 2016.
Stephen Hawking Medal recognizes the work of those helping to promote the public awareness of science through different disciplines such as science communication, music, arts and cinema.
Government GPS now has a new backup approach.
The Defense Advanced Research Projects Agency plans to demonstrate a positioning, navigation and timing system that will use very low frequency band signals as backup in case military forces lose access to GPS networks.
The Defense Advanced Research Projects Agency plans to demonstrate a positioning, navigation and timing system that will use very low frequency band signals as backup in case military forces lose access to GPS networks.Lin Haas, DARPA strategic technology officer, discussed the Spatial, Temporal and Orientation Information in Contested Environments project at DARPA Demo Day, the U.S. Army said May 19.
DARPA plans to demonstrate the STOIC system by fiscal year 2018 or 2019 while an at-sea demo will be conducted this year.
Interesting.
A team of Melbourne researchers believe they have discovered a new immune cell which is able to fight the infectious and potentially lethal bacteria, Legionella.
A team of specialist immunologists and microbiologists from the University of Melbourne and the Peter Doherty Institute for Infection and Immunity conducted a study which was able to determine a new cell type responsible for combating the attack of the bacteria.
The team was able to break down the impact of the legion of immune cells in the lung, which communicate to destroy the legionella bacteria.
Read more
